Rapamycin Mitigates Acute UV Skin Damage via Autophagy Activation
This preprint study investigates the protective mechanisms of rapamycin against acute ultraviolet B photodamage in a murine model. The researchers demonstrate that subcutaneous rapamycin administration rescues skin integrity by compensating for the absence of Hspb2, a heat shock protein critical for maintaining cellular autophagy. The pharmacological inhibition of mTOR by rapamycin successfully reduced cellular apoptosis and preserved dermal collagen networks.
Ultraviolet B radiation is a primary driver of extrinsic skin aging and genotoxicity. Acute exposure generates reactive oxygen species that induce DNA damage, trigger the p53 apoptotic cascade, and upregulate matrix metalloproteinases that degrade structural collagen. Mammalian cells typically rely on molecular chaperones like Hspb2 and the process of autophagy to clear misfolded proteins and halt cellular damage. When this self-repair mechanism fails, tissues exhibit accelerated aging phenotypes.
To isolate the cellular pathways involved in photoprotection, the research team utilized CRISPR/Cas9 technology to generate Hspb2 knockout mice. Following acute ultraviolet B irradiation, these genetically modified mice exhibited exacerbated skin damage compared to wild-type controls. The absence of Hspb2 led to severe thickening of the epidermis and a pronounced fragmentation of collagen fibers. Molecular analysis revealed that the knockout mice suffered from compromised autophagy, marked by elevated p62 levels and a reduced LC3II/I ratio, alongside heightened cellular apoptosis.
The introduction of rapamycin provided a robust pharmacological rescue of this accelerated damage model. Rapamycin acts as a specific inhibitor of the mechanistic target of rapamycin complex 1. By blocking this nutrient-sensing pathway, rapamycin forcefully induced autophagy in the skin tissue, bypassing the need for the Hspb2 chaperone. This restored autophagic flux was evidenced by the normalization of autophagosome markers.
Furthermore, rapamycin treatment actively suppressed the p53 apoptotic pathway. It favorably altered the ratio of pro-apoptotic to anti-apoptotic proteins, specifically decreasing Bax while preserving Bcl-2. Beyond cell survival, rapamycin exerted direct protective effects on the extracellular matrix. The drug activated the transforming growth factor beta signaling pathway, which suppressed the expression of collagen-degrading enzymes. Consequently, rapamycin-treated mice maintained functional Type I collagen networks despite the severe radiation exposure.
Actionable Insights
For longevity practitioners and biohackers, this research provides mechanistic validation that mTOR inhibition can protect the integumentary system from environmental stress. While systemic rapamycin is utilized for global longevity protocols, these data suggest targeted or systemic administration offers robust photoprotection against ultraviolet degradation.
The practical strength of the treatment effect is substantial in this acute damage model. Based on the genetic expression data, rapamycin treatment in the highly vulnerable knockout group reduced the expression of the pro-apoptotic Bax gene by approximately 69% and reduced p53 expression by roughly 45%. In wild-type mice exposed to ultraviolet radiation, rapamycin improved the dermal collagen volume fraction by a relative margin of roughly 40%.
These standardized percentage improvements indicate that mTOR inhibition does not merely delay cellular death but actively reverses the extracellular matrix degradation characteristic of photoaging. However, practitioners must note that this protocol tested subcutaneous injections, not topical formulations. Translation to human protocols would require controlled dosing to balance local immunosuppression against the benefits of enhanced autophagy and collagen retention.
Context/Source
- Title: Rapamycin Protects Mouse Skin from Ultraviolet B-Induced Photodamage by Modulating Hspb2-Mediated Autophagy and Apoptosis.
- Institution: The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University.
- Country: China.
- Journal Name: Research Square (Preprint Platform)
Preprint paper (open access):
RapamycinUVBSkinAgingSm.pdf (693.7 KB)